Drug Eluting Balloon in peripherAl inTErvention SFA

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 104 participants.

Also called NCT01556542

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; double masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 104 participants (enrolled count) (from the registry)
Sponsor
Leonardo Bolognese, MD (from the registry)
Registry
  • NCT NCT01556542
Other papers using this trial's data
  • Drug-eluting balloon in peripheral intervention for the superficial femoral artery: the DEBATE-SFA randomized trial (drug eluting balloon in peripheral intervention for the superficial femoral artery) JACC. Cardiovascular interventions, 2013-12 DOI, PubMed 24239203

Courtesy of the U.S. National Library of Medicine.

Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
Not reported
Countries
Italy (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT01556542. Randomized; double masking; primary purpose treatment. Start 2010-11 (registry gives no type); primary completion 2012-09 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Drug Eluting Balloon in peripherAl inTErvention SFA
Acronym
DEBATE SFA
Condition
Peripheral Arterial Disease
Intervention (Device)
paclitaxel-eluting balloon angioplasty followed by nitinol stent implantation
Intervention (Device)
nitinol stent implantation
Lead sponsor
Leonardo Bolognese, MD (class: other)

Record details

Record id
cardio:ct-nct01556542
Content hash
e7dae2d49e197d357084526615cd81d4677e4b112ef48145f7b4822dede065dd